Our Past
Clients and Partners:
Our Vision
from the beginning
Matoya Robinson’s professional background includes over 7 years of experience in biomedical research, with an additional 6 years of experience in R&D, nonprofit management, and science education prior to founding Micromattie Consulting in 2016. Her technical knowledge is combined with hands-on researchand development experience in molecular biology, retroviral vector design, microbiology, analytical chemistry, and polymer engineering.
In 2013 she realized that her skills were uniquely suited to ensure that initiatives led by clinicians, researchers, and policymakers remain directly rooted in the voices and needs of Americans living with chronic and rare diseases. Accordingly, she hung up her lab coat to begin consulting. 2016 saw the formal incorporation of Micromattie Consulting Inc, a minority woman owned business.
President
Matoya Robinson, MS MA
Ms. Robinson holds graduate degrees in Microbiology and Cell Science from the University of Florida and in Human Genetics and Molecular Biology from the Johns Hopkins School of Medicine, where she achieved PhD candidacy in 2011. From 2011 to 2013, she held a Graduate Research Fellowship in the NIH National Heart Lung and Blood Institute where she researched retroviral vector based gene therapy approaches to treat sickle cell disease and related genetic blood disorders.
Training Institutions
Speaking Engagements
In addition to management consulting, Mattie Robinson is also an accomplished public speaker. Request a booking using the button below.
Fees start at $2,500
News and Blog Posts
A Different Kind of Crisis: More Doctors Needed for Adults with Sickle Cell Disease
In the United States, children with Sickle Cell Disease (SCD) have more options than adults for their health management with
Perspectives from the People: Life with Sickle Cell Disease
Adults with sickle cell disease (SCD) shared their insights in a panel discussion at the 2018 Management of Sickle Cell
Long-Term and Adult-Onset Health Challenges of Sickle Cell Disease
An expansion of research interest in adult-onset complications of SCD, meaning secondary symptoms that are likely to first appear after